How has Anika Therapeutics's gain (loss) on disposition of assets changed year-over-year?

Anika Therapeutics's gain (loss) on disposition of assets decreased by 82.7% year-over-year, from $300K to $52K.

Anika Therapeutics ANIK Gain (Loss) on Disposition of Assets

Gain (Loss) on Disposition of Assets at other companies

Xtant Medical HoldingsXTNT

——

Globus MedicalGMED

——

Avanos MedicalAVNS

——

Other financials

Income statement

See full

Revenue$29.6M+13.2%

Net income-$5.1M-3.8%

Balance sheet

See full

Cash & equivalents$41.0M-23.1%

Total debt$25.7M+1.2%

Total equity$133.9M-9.8%

Total assets$179.4M-5.9%

Cash flow

See full

Operating cash flow-$4.8M-3,628%

CapEx$1.4M-49.3%

Free cash flow-$6.3M-112%

Valuation

See full

Market cap$204.37M+31.6%

Enterprise value$189.09M+48.7%

P/S1.8×+0.1×

Profitability

See full

Net margin-9.8%-4.4pp

FCF margin0.9%—

Returns & leverage

See full

Return on equity-8%-3.4pp

Debt / equity0.2×0.0×

Current ratio4.5×-1.3×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's gain (loss) on disposition of assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Anika Therapeutics's gain (loss) on disposition of assets?: Anika Therapeutics (ANIK) reported gain (loss) on disposition of assets of $52K in Q1 2026.
How has Anika Therapeutics's gain (loss) on disposition of assets changed year-over-year?: Anika Therapeutics's gain (loss) on disposition of assets decreased by 82.7% year-over-year, from $300K to $52K.